Endomucin, a vascular endothelial marker, staining for determining tumour microvessel density demonstrated a 21% decrease with NPT+Gem, 60% decrease with αMMP9 and 65% decrease with NPT+Gem+αMMP9 therapy (Figure 4). This evidence concerns the gene EMCN and neoplasm.